Biofrontera (BFRI) Change in Cash (2020 - 2025)
Biofrontera's (BFRI) quarterly Change in Cash came in at $3.0 million in Q4 2025, down 1.88% year-on-year from $3.0 million in Q4 2024, and up 177.84% quarter-over-quarter from -$3.8 million in Q3 2025.
Biofrontera (BFRI) Change in Cash (2020 - 2025) Analysis & Trends
Biofrontera's Change in Cash history runs 6 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- On a quarterly basis, Change in Cash fell 1.88% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $487000.0, a 89.32% decrease from a year earlier, with the FY2025 full-year figure at $487000.0, down 89.32% from the prior year.
- Change in Cash improved to $3.0 million in Q4 2025 per BFRI's latest filing, from -$3.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $22.8 million in Q4 2021 and bottomed at -$10.4 million in Q4 2022.
- The 5-year median for Change in Cash is -$1.5 million (2021), against an average of -$84250.0.
- Biggest YoY gain for Change in Cash was 870.46% in 2025; the steepest drop was 266.53% in 2025.
- Year by year, Change in Cash stood at $22.8 million in 2021, then tumbled by 145.37% to -$10.4 million in 2022, then soared by 79.93% to -$2.1 million in 2023, then surged by 245.84% to $3.0 million in 2024, then slipped by 1.88% to $3.0 million in 2025.
- Per Business Quant, the three latest BFRI Change in Cash figures stand at $3.0 million (Q4 2025), -$3.8 million (Q3 2025), and $5.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | -3.82 Mn |
| Jun 30, 2025 | 5.45 Mn |
| Mar 31, 2025 | -4.12 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | 562,000.00 |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | -2.08 Mn |
| Sep 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | -9.05 Mn |
| Mar 31, 2023 | -3.70 Mn |
| Dec 31, 2022 | -10.36 Mn |
| Sep 30, 2022 | -4.35 Mn |
| Jun 30, 2022 | 9.49 Mn |
| Mar 31, 2022 | -2.12 Mn |
| Dec 31, 2021 | 22.83 Mn |
| Sep 30, 2021 | -1.34 Mn |
| Jun 30, 2021 | -1.59 Mn |
| Mar 31, 2021 | -3.44 Mn |